Abstracts

Quantifying the rate of blood glucose changes over the acute stage of ischemic stroke among patients with diabetes.

Thursday 16 October, 2025

Objectives: Hyperglycemia (HG) during acute ischemic stroke (AIS) is associated with poor outcomes. Diabetes mellitus (DM) is an independent predictor…

Read more

Characterization of SARS-CoV-2 variants of concern viral dynamics in non-human primates

Thursday 16 October, 2025

Introduction Since the beginning of the pandemic several SARS-CoV-2 variants have emerged and although most of them vanished quickly, some…

Read more

Developing a model of SARS-CoV-2 viral dynamics under monoclonal antibody treatment.

Thursday 16 October, 2025

Introduction: After more than a year of an unprecedented pandemic, it remains critical to find effective anti-viral strategies against SARS-CoV-2…

Read more

Effect of CYP2D6 genotype on pharmacokinetics and pharmacodynamics of carvedilol for the heart rate reduction in healthy subjects

Thursday 16 October, 2025

Objectives: Carvedilol is an adrenergic receptor antagonist and used as first-line therapy for cardiovascular disease including hypertension. It is mainly…

Read more

Model Averaging Across Parametric and Non-Parametric Methods as an Aid for Clinical Decision Making

Thursday 16 October, 2025

Objectives: Randomized clinical trials (RCTs) are the main tool to generate patient-level data. The main analysis method of such data is…

Read more

Parametric and Non-Parametric Methods in Clinical Decision Making- A Comparison of Bias and Precision using Real Clinical Data

Thursday 16 October, 2025

Objectives: Non-parametric Mixed Models for Repeated Measures (MMRM) have evolved to be the gold standard for disease progression data analysis…

Read more

A Semi Parametric Method for the Estimation of End of Treatment Effect

Thursday 16 October, 2025

Objectives: End of treatment effect is a commonly used endpoint in Randomized Clinical Trials (RCTs). Several methods are used for…

Read more

Evaluating two strategies for the design of pediatric pharmacokinetic studies

Thursday 16 October, 2025

Objectives: Designing pediatric clinical trials are complicated by the large range of body sizes and developmental changes in the population…

Read more

Relative bioavailability of delamanid dispersed in water in healthy volunteers

Thursday 16 October, 2025

Objectives: Delamanid is a nitro-dihydro-imidazooxazole antibiotic which derives its antimycobacterial activity from inhibiting mycolic acid synthesis. A delamanid tablet of…

Read more

A novel approach to evaluate the design of pediatric PK studies focused on accurate dose selection

Thursday 16 October, 2025

Objectives: A commonly used criterion to justify the design of a pediatric PK study is that the study must be…

Read more